Home >
Medicine Info >
Carvidon 35 mg Tablet MR
Loading interface...

Carvidon 35 mg Tablet MR

Manufactured byMicro Labs Ltd.
ContainsTrimetazidine
Description
Carvidon 35 mg Tablet MR is an anti-anginal medicine. It is used as an additional treatment for stable angina pectoris (chest pain caused due to reduced blood flow to the heart). This medicine is used when a person does not respond adequately to other medicines or is intolerant to first-line anti-anginal medicines (initial, preferred, or best treatment for angina). Carvidon 35 mg Tablet MR increases the utilization of glucose (sugar) in place of fat, which results in a steady and more efficient energy supply to the heart muscles. As a result, in people with decreased heart function or blood supply that may cause hypoxia (low oxygen supply), the energy requirements of the heart and its functioning are not reduced. Thus, it protects the heart from any effects of low oxygen supply during angina. Carvidon 35 mg Tablet MR may cause dizziness, headache, abdominal pain, diarrhoea, indigestion, rash, etc. Consult your doctor if these side effects persist or worsen. Avoid driving vehicles or operating machines if you feel dizzy or tired after taking this medicine. Do not take this medicine if you are allergic to it. Carvidon 35 mg Tablet MR should be taken twice daily with meals, once in the morning and once in the evening. For ease of remembering, take this medicine at the same time every day. Your doctor will decide the dose and duration of treatment based on your condition. Do not stop taking this medicine without consulting your doctor, as it may worsen your condition. Carvidon 35 mg Tablet MR may not be suitable for everyone, especially if you have movement disorders like tremors, restless leg syndrome, etc. It is not recommended for use if you have Parkinson's disease (a brain disorder that causes a gradual loss of muscle control) or severe kidney conditions. Consult your doctor before taking this medicine if you are pregnant, planning a pregnancy, or breastfeeding.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Carvidon 35 mg Tablet MR

Trivedon 35 mg Tablet MR
Cipla Ltd.

Side effects

Major & minor side effects for Carvidon 35 mg Tablet MR

  • Hypersensitivity
  • Headache
  • Nausea and vomiting
  • Abdominal pain
  • Fatigue
  • Asthenia (Decreased muscle strength)
  • Skin itching
  • Dizziness

Uses of Carvidon 35 mg Tablet MR

What is it prescribed for?

  • Angina pectoris
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for Carvidon 35 mg Tablet MR to show its action is not clinically established.
  • How long do the effects of this medicine last?
    Carvidon 35 mg Tablet MR remains effective in the body for approximately 12 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Carvidon 35 mg Tablet MR.
  • Can this medicine be taken during pregnancy?
    Carvidon 35 mg Tablet MR is not recommended for use during pregnancy unless absolutely necessary. All the risks and benefits should be discussed with your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Carvidon 35 mg Tablet MR is not recommended for use while breastfeeding unless absolutely necessary. All the risks and benefits should be discussed with your doctor before taking this medicine.

Allergy

Avoid taking Carvidon 35 mg Tablet MR if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.

Parkinson's disease

Carvidon 35 mg Tablet MR is not recommended for use if you have Parkinson's disease (a brain disorder that causes a gradual loss of muscle control), as it may worsen your condition.

Severe kidney impairment

Carvidon 35 mg Tablet MR is not recommended for use if you have severe kidney impairment due to the increased risk of worsening of the condition.
Warnings for special population

Pregnancy

Carvidon 35 mg Tablet MR is not recommended for use during pregnancy unless absolutely necessary. All the risks and benefits should be discussed with your doctor before taking this medicine.

Breast-feeding

Carvidon 35 mg Tablet MR is not recommended for use while breastfeeding unless absolutely necessary. All the risks and benefits should be discussed with your doctor before taking this medicine.
General warnings

Use in paediatrics

Carvidon 35 mg Tablet MR is not recommended for use in children less than 18 years of age as the safety and efficacy data are not clinically established.

Use in the elderly

Carvidon 35 mg Tablet MR should be used with caution in the elderly above the age of 75 years due to the increased risk of side effects.

Emergency use

Carvidon 35 mg Tablet MR is not recommended as an initial treatment for unstable angina (unexpected chest pain that usually occurs while resting) or heart attack, in the pre-hospital phase, or during the first few days of hospitalization. This medicine is also not a curative treatment for angina. Your doctor may prescribe this medicine after your condition has stabilized.

Driving or operating machines

Use of Carvidon 35 mg Tablet MR may cause blurred vision or dizziness. It is advised that you do not perform any activities such as driving vehicles or operating machines if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose of Carvidon 35 mg Tablet MR as soon as you remember. Skip the missed dose if it is almost time for the next scheduled dose. Do not double the dose to make up for the missed one.

Overdose

Never take more than the prescribed dose. If you suspect that you might have taken an overdose of Carvidon 35 mg Tablet MR, seek immediate medical help.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Metoclopramide

Disease interactions

Kidney disease

Carvidon 35 mg Tablet MR should be used with caution if you have kidney problems, as it may cause the accumulation of the medicine in the body and cause an increased risk of side effects.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Carvidon 35 mg Tablet MR exactly as advised by the doctor. Do not take in larger amounts than prescribed. Do not break, chew, or crush the tablet. Swallow as a whole with water. Consult your doctor if you experience any undesirable effects that persist or worsen. Do not stop the use of this medicine without consulting your doctor. Avoid driving vehicles or operating heavy machines if you feel dizzy or drowsy after taking this medicine.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

May cause sleepiness

How it works
Carvidon 35 mg Tablet MR increases the utilization of glucose in place of fat to create a steady and more efficient energy supply to the heart muscles. As a result, in people with decreased heart function or blood supply that may result in hypoxia (low oxygen supply), the energy requirements of the heart and its functioning are not reduced.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Antianginal agents, Vasodilators

Schedule

Schedule H

Drugs.ncats.io. 2021. NCATS Inxight: Drugs. [online] Available at: [Accessed 12 October 2021].

https://drugs.ncats.io/substances?q=%22Trimetazidine%22&facet=Substance%20Form%2FPrincipal%20Form

Pubchem.ncbi.nlm.nih.gov. 2021. Trimetazidine. [online] Available at: [Accessed 12 October 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Trimetazidine

CiplaMed. 2021. TRIVEDON MR Tablets. [online] Available at: [Accessed 13 October 2021].

https://ciplamed.com/content/trivedon-mr-tablets
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 14 Sep 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.